See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $22.7B | 8.9x | 37.6x | |
| $9.2B | 387.1x | -8.5x | |
| $7.1B | 5.4x | 21.6x | |
| $4.3B | n/a | n/a | |
| $3.7B | 13.8x | 36.1x | |
| $3.5B | 3.0x | 10.7x | |
| $2.2B | n/a | n/a | |
| $2.2B | 18.3x | n/a | |
| $2.1B | 36.5x | 1.5x | |
| $1.6B | 4.9x | n/a | |
| $1.4B | 41.8x | -210.9x | |
| $770M | 20.5x | -4.0x | |
| $622M | 7.6x | -207.2x | |
| $430M | n/a | n/a | |
| $422M | 88.1x | -3.8x | |
| $339M | 28.3x | -242.9x | |
| $317M | n/a | n/a | |
| $253M | 3.3x | 13.0x | |
| $243M | 53.5x | n/a | |
| $242M | 5.6x | -12.4x | |
| $203M | n/a | n/a | |
| $121M | n/a | n/a | |
| $120M | 10.4x | -6.5x | |
| $117M | 305.2x | n/a | |
| $97.7M | 4.5x | -63.5x | |
| $83.1M | 14.6x | -19.4x | |
| $75.6M | 16.4x | -3.4x | |
| $70.2M | n/a | n/a | |
| $62.7M | 23.9x | n/a | |
| $58.3M | n/a | n/a | |
| $53.0M | n/a | n/a | |
| $49.0M | 7.5x | -11.9x | |
| $41.9M | 282.5x | n/a | |
| $40.3M | n/a | n/a | |
| $27.5M | 25.6x | n/a | |
| $23.3M | n/a | -1.5x | |
| $20.3M | 29.4x | n/a | |
| $11.5M | n/a | n/a | |
| $10.6M | 4.6x | -0.4x | |
| -$0.2M | n/a | n/a | |
| -$4.2M | -1.5x | n/a | |
| -$6.2M | n/a | n/a | |
| -$47.5M | -0.7x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems